Related references
Note: Only part of the references are listed.Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).
Aly-Khan A. Lalani et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC).
Hans J. Hammers et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.
Patrick Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)
Shankar Siva et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac
William A. Hal et al.
PLOS ONE (2020)
Reliability of ITV approach to varying treatment fraction time: a retrospective analysis based on 2D cine MR images
Davide Cusumano et al.
RADIATION ONCOLOGY (2020)
Treatment plan quality during online adaptive re-planning
Janita E. van Timmeren et al.
RADIATION ONCOLOGY (2020)
ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium
Ernst S. Kooreman et al.
RADIOTHERAPY AND ONCOLOGY (2020)
The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
Shyama U. Tetar et al.
CANCERS (2020)
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Sophie R. de Mol van Otterloo et al.
FRONTIERS IN ONCOLOGY (2020)
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
Camillo Porta et al.
KIDNEY INTERNATIONAL (2020)
Epidemiology of Renal Cell Carcinoma
Sandeep Anand Padala et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Epidemiology of Renal Cell Carcinoma
Umberto Capitanio et al.
EUROPEAN UROLOGY (2019)
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2019)
Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK
Rohann J. M. Correa et al.
JOURNAL OF UROLOGY (2019)
Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator
Ernst S. Kooreman et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The SURTIME Randomized Clinical Trial
Axel Bex et al.
JAMA ONCOLOGY (2019)
Intrafraction Motion Management of Renal Cell Carcinoma With Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy
Fieke M. Prins et al.
PRACTICAL RADIATION ONCOLOGY (2019)
Magnetic Resonance Image Guided Stereotactic Body Radiation Therapy to the Primary Renal Mass in Metastatic Renal Cell Carcinoma
Soumon Rudra et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Adaptive radiotherapy: The Elekta Unity MR-linac concept
Dennis Winkel et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis
John R. van Sornsen de Koste et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
First clinical implementation of real-time, real anatomy tracking and radiation beam control
Olga L. Green et al.
MEDICAL PHYSICS (2018)
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A. Mejean et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
Lauren Henke et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR
Davide Cusumano et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Patient-Reported Quality of Life Following Stereotactic Body Radiation Therapy for Primary Kidney Cancer: Results from a Prospective Cohort Study
A. Swaminath et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The radiobiological impact of motion tracking of liver, pancreas and kidney SBRT tumors in a MR-linac
Shahad Al-Ward et al.
PHYSICS IN MEDICINE AND BIOLOGY (2018)
Pooled Analysis of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)
Shankar Siva et al.
CANCER (2018)
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone
Kristian M. Koller et al.
CANCER BIOLOGY & THERAPY (2017)
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang et al.
CLINICAL CANCER RESEARCH (2017)
Renal Mass and Localized Renal Cancer: AUA Guideline
Steven Campbell et al.
JOURNAL OF UROLOGY (2017)
A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma
Guozhu Xie et al.
CANCER BIOLOGY & THERAPY (2017)
Effect of intra-fraction motion on the accumulated dose for free-breathing MR-guided stereotactic body radiation therapy of renal-cell carcinoma
Bjorn Stemkens et al.
PHYSICS IN MEDICINE AND BIOLOGY (2017)
A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Anurag K. Singh et al.
CLINICAL CANCER RESEARCH (2017)
Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience
J. H. Chang et al.
CLINICAL ONCOLOGY (2016)
Evaluation of kidney motion and target localization in abdominal SBRT patients
Marcus Sonier et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2016)
Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy
Marcus Sonier et al.
Medical Dosimetry (2016)
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system
Yingli Yang et al.
MEDICAL PHYSICS (2016)
Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma
Yan Wu et al.
DISEASE MARKERS (2015)
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
Lee Ponsky et al.
RADIOTHERAPY AND ONCOLOGY (2015)
The Use of Dual Vacuum Stabilization Device to Reduce Kidney Motion for Stereotactic Radiotherapy Planning
Daniel Pham et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2015)
Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer
Daniel Pham et al.
PRACTICAL RADIATION ONCOLOGY (2015)
Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus
Ricardo A Rendon et al.
CUAJ-Canadian Urological Association Journal (2014)
The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
Sasa Mutic et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers
S. Kuku et al.
BRITISH JOURNAL OF CANCER (2013)
An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy
Shankar Siva et al.
RADIATION ONCOLOGY (2013)
RADIATION DOSE-VOLUME EFFECTS IN THE STOMACH AND SMALL BOWEL
Brian D. Kavanagh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations
Zachary Klinghoffer et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model
Lance Walsh et al.
EUROPEAN UROLOGY (2006)
Rising incidence of small renal masses: A need to reassess treatment effect
John M. Hollingsworth et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy
S Köst et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)
Share Paper
